HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

3rd Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 24-26, 2022 | Orlando, Florida, USA

ce-approved

GAB 2019

Jonathan Chick, Speaker at Speaker for GAB Conferences- Jonathan Chick
Keynote Presentation (In-Person)
Jonathan Chick, Consultant Psychiatrist and Medical Director, Castle Craig Hospital, United Kingdom

Depression, anxiety, impulsivity, difficulty concentrating, mood swings and occasionally psychotic symptoms are recognised symptoms in addiction to mind-altering substances.Sufferers who protect their use of the substance may precipitate GPs and psychiatrists into inappropriate p [....] » Read More

Leo O Lanoie, Speaker at Speaker for GAB Conferences- Leo O Lanoie
Keynote Presentation (In-Person)
Leo O Lanoie, Saskatchewan Health Authority, Canada

Persons with Substance Use Disorder are subject to a host of medical, psychiatric and social conditions that predispose to SUD and/or complicate it. These conditions negatively impact quality of life, and all to frequently can end life if not recognized and addressed. Many per [....] » Read More

Rajendra D Badgaiyan, Speaker at Addiction Conferences
Keynote Presentation (In-Person)
Rajendra D Badgaiyan, South Texas Veteran Health Care System, United States

Dopamine plays a predominant role in establishment and maintenance of addiction. The precise mechanism involved in this process however is unclear. An important reason for our lack of knowledge is difficulties associated with measurement of dopamine release in healthy human brain [....] » Read More

Alf Martin Haraldsen, Speaker at Speaker for GAB Conferences- Alf Martin Haraldsen
Keynote Presentation (In-Person)
Alf Martin Haraldsen, General Practitioner, Norway

Is it possible to reduce “Opioid overdose deaths” by more than 50%? Opioids (heroin/methadone/morphine/phentanyl/buprenorphine etc.) contributes to about 70-80% of total “Drug related deaths”(DRD) in a country. DRD is the parameter used by the EU in its an [....] » Read More

Helen Snooks, Speaker at Speaker for GAB Conferences- Helen Snooks
Oral Presentation
Helen Snooks, Medical School, Swansea University, United Kingdom

Background Opioids such as heroin kill more people worldwide than any other drug. In the UK, death from opioid poisoning is at record levels. Naloxone is an opioid agonist which can be distributed in take home ‘kits’, known as Take Home Naloxone (THN). Methods [....] » Read More

Joan Carlson, Speaker at Speaker for GAB Conferences- Joan Carlson
Oral Presentation
Joan Carlson, Indiana University, United States

The purpose of this paper is to describe the development and implementation of a multi-disciplinary curriculum and training of screening, brief intervention and referral to treatment (SBIRT) at a large mid-western university in the U.S. The program called “Advancing Mu [....] » Read More

Pasqualina Rocco, Speaker at Speaker for GAB Conferences- Pasqualina Rocco
Oral Presentation
Pasqualina Rocco, Addiction Treatment Center, Local Health Service, Italy

Introduction: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that in most cases persists into adulthood. Often associated with other psychiatric disorders and the most frequent is substance use disorder. The ADHD-substance use comorbidity ha [....] » Read More

Derek Loewy, Speaker at Speaker for GAB Conferences- Derek Loewy
Oral Presentation
Derek Loewy, Scripps Clinic Viterbi Family Sleep Center, United States

For many years, the most common medical treatment for chronic insomnia has been sedative hypnotic drugs. Chief among these have been benzodiazepines and the so called “non-benzodiazepine” drugs (i.e., zolpidem, eszopiclone) which act more selectively on GABA receptors [....] » Read More

Amy Turnbull Drilingas, Speaker at Speaker for GAB Conferences- Amy Turnbull Drilingas
Oral Presentation
Amy Turnbull Drilingas, FCC Behavioral Health Cape Girardeau, United States

The therapeutic relationship can be a powerful catalyst to engage clients in building healthy relationships with others and healing from the trauma in their past. While most practitioners can agree that the therapeutic alliance is important, there has been a change of focus that [....] » Read More

Jay Hansford C Vest, Speaker at Speaker for GAB Conferences- Jay Hansford C Vest
Oral Presentation
Jay Hansford C Vest, University of North Carolina at Pembroke, United States

In 2001, while teaching at Hamilton College in Clinton, New York, a former student – having taken my Native American Religious traditions course - sought me; he complained of soul sickness after experimenting with an opiod.  Receiving him within the context of my indig [....] » Read More

Stephanie Kewley, Speaker at Speaker for GAB Conferences- Stephanie Kewley
Oral Presentation
Stephanie Kewley, Liverpool John Moores University, United Kingdom

It is well documented that engaging with arts-based activities, provides general populations a wide range of social, health, and well-being benefits. Yet, the evidence for arts-based activities delivered with/to people in drug and alcohol recovery treatment communities, in the UK [....] » Read More

Marija Saric Drnas, Speaker at Speaker for GAB Conferences- Marija Saric Drnas
Oral Presentation
Marija Saric Drnas, Faculty of Education,University of Zagreb, Croatia (Hrvatska)

A multidimensional approach to studying aggressive behaviour is based on a distinction between the various functions and various forms of aggression. The function of aggressive behaviour is related to the motive of the perpetrator. Therefore, a distinction is made between reactiv [....] » Read More

Fruzsina I, Speaker at Speaker for GAB Conferences- Fruzsina Iszaj
Oral Presentation
Fruzsina I, Károli Gáspár University of the Reformed Church, Budapest, Hungary

The focus of the presentation will be the effects of practicing yoga on addictions. From the point of addiction theories, the connection between emotional regulation and addictive disorders is emphasized. Psychoactive substance use can be interpreted as a tool for balancing extre [....] » Read More

Josephine Ridley, Speaker at Speaker for GAB Conferences- Josephine Ridley
Oral Presentation
Josephine Ridley, VA Northeast Ohio Healthcare System, United States

Somewhere in the world, someone dies by suicide every 40 seconds (WHO, 2014). The relationship between depression and suicide is complicated. In the U.S., mental health problems were the most commonly found precipitating circumstance to suicide with roughly 38% describing a depre [....] » Read More

Lidia Moutinho, Speaker at Speaker for GAB Conferences- Lídia Moutinho
Oral Presentation
Lidia Moutinho, Lisbon Psychiatric Hospital Center, Portugal

Clinical epidemiology supported by neuroscience shows a strong interconnection between psychiatric disorders and substance use/abuse. This comorbidity is recognized by the World Health Organization as Dual Pathology. It is estimated that a percentage varying between 40% and 70% o [....] » Read More

Hans B Dupont, Speaker at Speaker for GAB Conferences- Hans B Dupont
Oral Presentation
Hans B Dupont, Maastricht University, Netherlands

The Moti-4 intervention, in which motivational interviewing, self–monitoring, and strengthening behavioral control are used, was developed in the Netherlands in response to several rapid assessments of problematic use of cannabis among vulnerable adolescents. The main goal [....] » Read More

T  Wing Lo, Speaker at Speaker for GAB Conferences- T. Wing Lo
Oral Presentation
T Wing Lo, University of Hong Kong, Hong Kong

The paper examines the issue of hidden drug abuse in Hong Kong. Although of?cial statistics show that the reported number of drug-abuse cases has been in decline in recent years, it has been reported that drug abusers tend to hide themselves at home to take drugs; thus, they are [....] » Read More

Yaacov J Katz, Speaker at Speaker for GAB Conferences- Yaacov J Katz
Oral Presentation
Yaacov J Katz, Bar-Ilan University, Israel

Religiosity may be defined as the adoption of a core set of previously established religious beliefs and practices concerning the ultimate nature of life and existence. Religiosity seems to reliably predict lower levels of substance abuse (Yonker, Schnabelrauch, & De Haan, 20 [....] » Read More

Mbachu Chioma Ngozichukwu Pauline, Speaker at Speaker for GAB Conferences- Mbachu Chioma Ngozichukwu Pauline
Oral Presentation
Mbachu Chioma Ngozichukwu Pauline, Nnamdi Azikiwe University Teaching Hospital,, Nigeria

Use of Psychoactive substances by adolescents and young people poses a significant public health threat despite mass campaigns and education. Adolescence being a period of transition from childhood to adulthood is a potential target for health education aimed at initiating and ma [....] » Read More

Scott Stevens, Speaker at Speaker for GAB Conferences- Scott Stevens
Oral Presentation
Scott Stevens, Alcohologist.com, United States

The decade of the 2010's shelled hospitals and first responders with an explosion of opioid-related illness, injury, and death. Preventable drug overdoses tallied 54,793 lives lost in 2016 – an increase of 391 percent since 1999. Accidental drug overdose deaths increase [....] » Read More

Sam V, Speaker at Speaker for GAB Conferences- Sam Vaknin
Video Presentation
Sam V, Southern Federal University, Russian Federation

he unpalatable truth is that falling in love is, in some ways, indistinguishable from a severe pathology. Behavior changes are reminiscent of psychosis and, biochemically speaking, passionate love closely imitates substance abuse. Appearing in the BBC series Body Hits on December [....] » Read More

David J McCann, Speaker at Speaker for GAB Conferences- David J McCann
Keynote Presentation (In-Person)
David J McCann, National Institute on Drug Abuse, United States

For almost 30 years, the U.S. National Institute on Drug Abuse (NIDA) has supported development of medications for the treatment of substance use disorders and their consequences.  Working in close partnership with the private sector and the U.S. Food and Drug Administration [....] » Read More

Noel Busch Armendariz, Speaker at Speaker for GAB Conferences- Noel Busch Armendariz
Keynote Presentation (In-Person)
Noel Busch Armendariz, University of Texas at Austin, United States

This session will focus on a discussion about the Cultivating Learning and Safe Environments (CLASE), a 5-year comprehensive and scientific effort to eradicate intimate and interpersonal violence at all 14 University of Texas (UT) System Institutions of Higher Education (IHEs). A [....] » Read More

Anna Gagat Matula, Speaker at Speaker for GAB Conferences- Anna Gagat Matula
Keynote Presentation (In-Person)
Anna Gagat Matula, Pedagogical University of Cracow, Poland

The aim of studies was to recognise social communication and addiction to computer games  among adolescents with Asperger Syndrome. The character of studies was pilot. In this research under diagnostic survey the authorship questionnaire survey was used. he study was conduct [....] » Read More

Scott Giacomucci, Speaker at Speaker for GAB Conferences- Scott Giacomucci
Keynote Presentation (In-Person)
Scott Giacomucci, Phoenix Center for Experiential Trauma Therapy, United States

This interactive presentation will highlight the connection between addiction and trauma while emphasizing the importance of providing treatment that addresses both. Experiential Therapy will be introduced as an alternative to traditional talk therapy. The triadic system of J.L. [....] » Read More

Matt Kammer Kerwick, Speaker at Speaker for GAB Conferences- Matt Kammer Kerwick
Oral Presentation
Matt Kammer Kerwick, University of Texas at Austin, United States

This presentation will focus on the methodology of conducting a 5-year comprehensive and scientific effort to study and reduce intimate and interpersonal violence at all 14 University of Texas (UT) System Institutions of Higher Education (IHEs). It will also present findings spec [....] » Read More

Bruce Kellison, Speaker at Speaker for GAB Conferences- Bruce Kellison
Oral Presentation
Bruce Kellison, University of Texas at Austin, United States

This presentation will focus on the methodology of conducting a 5-year comprehensive and scientific effort to study and reduce intimate and interpersonal violence at all 14 University of Texas (UT) System Institutions of Higher Education (IHEs). It will also present findings spec [....] » Read More

Bridget C Bailey, Speaker at Speaker for GAB Conferences- Bridget C Bailey
Oral Presentation
Bridget C Bailey, The Ohio State University College of Social Work, United States

Medication Assisted Treatment (MAT) is the gold standard for treatment of opioid use disorder (OUD) and is preventing OUD related overdose deaths. To increase the provider capacity in administering MAT, the U.S. Drug Addiction Treatment Act 2000 (DATA 2000) enabled physicians to [....] » Read More

Jorge Juarez, Speaker at Speaker for GAB Conferences- Jorge Juarez
Oral Presentation
Jorge Juarez, Instituto de Neurociencias, Universidad de Guadalajara, Mexico

It has been described a b-endorphin deficiency in alcoholic patients or in men with a family history of alcoholism. It is well known that alcohol consumption release b-endorphin from hypothalamus; therefore, it has been hypothesized that high alcohol intake in alcoholics could be [....] » Read More

Nuno Albuquerque, Speaker at Speaker for GAB Conferences- Nuno Albuquerque
Oral Presentation
Nuno Albuquerque, UK Addiction Treatments, United Kingdom

Treating addiction – whether at rehab or not – can be divided into three main phases. Firstly, is detoxification, the process by which an addict’s system is cleansed of substances of abuse. Once this cleansing process has taken place, and the immediate pressures [....] » Read More

Geoff Mascall, Speaker at Speaker for GAB Conferences- Geoff Mascall
Oral Presentation
Geoff Mascall, UK Addiction Treatment Centres, United Kingdom

Treating addiction – whether at rehab or not – can be divided into three main phases. Firstly, is detoxification, the process by which an addict’s system is cleansed of substances of abuse. Once this cleansing process has taken place, and the immediate pressures [....] » Read More

Deborah Mosby, Speaker at Speaker for GAB Conferences- Deborah Mosby
Oral Presentation
Deborah Mosby, Metropolitan State University, United States

It is a well-known fact, that in addictions counselling, success rates are dubious at best and recidivism is high. In any other industry, would you pay for a service that only worked 50% of the time?  Many treatment centers lack follow-up with clients and boast high success [....] » Read More

Ying Ying Leung, Speaker at Speaker for GAB Conferences- Ying Ying Leung
Oral Presentation
Ying Ying Leung, Middlesex University, Hong Kong

Introduction DSM-V has re-categorized gambling disorder as an addiction rather than impulsive control disorder. Recent research studies found that gambling among youths has been increasing in Hong Kong. Objectives The current study aims to explore how individuals dev [....] » Read More

Catherine De Jong, Speaker at Speaker for GAB Conferences- Catherine De Jong
Oral Presentation
Catherine De Jong, Miroya Foundation, Netherlands

Background: Since the year 2000, oral Naltrexone in combination with Cognitive Behavioural Therapy (CBT) has been implemented at our clinic for relapse prevention after opiate detoxification. Naltrexone implants were introduced in 2003. All patients receive a 6-week or 2-month im [....] » Read More

George O Neil, Speaker at Speaker for GAB Conferences- George O Neil
Oral Presentation
George O Neil, University of Western Australia, Australia

Addiction is managed by Recovery based organisations meeting psychosocial needs in a protected setting. Medical practitioners are using agonists typically to the opioid and GABA systems supplemented by antidepressants and antipsychotics.  Medical practitioners using [....] » Read More

Hattie Moyes, Speaker at Speaker for GAB Conferences- Hattie Moyes,
Oral Presentation
Hattie Moyes, The Forward Trust, United Kingdom

This presentation will assess the scale of the problem of new psychoactive substances (NPS) in English prisons and the impact they have on prisoner mental health. NPS is predominantly a prison problem – the use of NPS is much higher in prisons than in the community. Prisone [....] » Read More

Laurence Armand French, Speaker at Speaker for GAB Conferences- Laurence Armand French
Oral Presentation
Laurence Armand French, University of New Hampshire, United States

Problem:  The United States is undergoing a drug crisis of epic proponent - one that crosses racial, ethnic, and socio-economic/class divides giving new emphasis on prevention and treatment and not just criminal adjudication. Currently, drug-related overdose in the United St [....] » Read More

Danilo Tittarelli, Speaker at Speaker for GAB Conferences- Danilo Tittarelli
Oral Presentation
Danilo Tittarelli, Addiction and Mental Health Department, Italy

This talk intends to examine, both from a psychopathological and a phenomenological perspective, the state of “being-at-the-world”, which is common in individuals with drug addiction. Past abuse, as well as present abuse, are crucial in the modification of the psychia [....] » Read More

Meliha Bijedic, Speaker at Speaker for GAB Conferences- Meliha Bijedic
Oral Presentation
Meliha Bijedic, University of Tuzla, Bosnia and Herzegowina

Gambling is a widespread activity in Bosnia & Herzegovina, young people grow up in a context where gambling is very available, accessible and positively promoted. Although gambling is illegal for minors, many adolescents gamble   and   suffer from a wide r [....] » Read More

Xiaowei Guan, Speaker at Speaker for GAB Conferences- Xiaowei Guan
Oral Presentation
Xiaowei Guan, Vice Dean of School of Medicine and Life Sciences, China

Addiction to methamphetamine (METH) and other psychostimulants represents a major public health crisis, which causing serious burdens to society and the economy. Nowadays, the number of meth abuser has increased rapidly, and meth has become one of most common abused drugs in Chin [....] » Read More

Zengzhen Wang, Speaker at Speaker for GAB Conferences- Zengzhen Wang
Oral Presentation
Zengzhen Wang, Tongji Medical College, China

Objective To explore the effects of five-step desensitization therapy combined with question recalling, vipassana meditation, eye movement desensitization and reprocessing (EMDR), hypnotherapy and neural language programs (NLP) on addictive memory and self-esteem levels in p [....] » Read More

Corinne Fitzgerald, Speaker at Speaker for GAB Conferences- Corinne Fitzgerald
Poster Presentation
Corinne Fitzgerald, Swiss Re Institute, United Kingdom

Common mental disorders, comprised of both depressive and anxiety disorders, affect approximately 586million people globally (WHO, 2017). Given the stigma associated with mental disorders, as well as reliability in reporting and monitoring or conditions, this number could be sign [....] » Read More

Feifei Ge, Speaker at Speaker for GAB Conferences- Feifei Ge
Poster Presentation
Feifei Ge, Nanjing University of Chinese Medicine, China

MicroRNA-134 (miR-134) is abundantly expressed in the hippocampus and play important roles in the process of brain development and neuropsychiatric disorders. The present study aims to explore whether miR-134 involves in cocaine exposure related psychiatric disorders and the mech [....] » Read More

Olga Inozemtseva, Speaker at Speaker for GAB Conferences- Olga Inozemtseva
Poster Presentation
Olga Inozemtseva, Universidad de Guadalajara, Guadalajara, Mexico

The loss of inhibitory control (IC) has been closely associated with addictive behaviors. The IC is a cognitive process that has considerably influence in the behavioral regulation. Alterations in IC in patients with substance use disorder have been identified mainly in inhibitor [....] » Read More

Yih Tsu Hahn, Speaker at Speaker for GAB Conferences- Yih Tsu Hahn
Poster Presentation
Yih Tsu Hahn, Shih Chien University, Taiwan

The population of substance abuse co-occurring social issues is increasing in Taiwan over the last years. In the professions of rehabilitation and recovery, how to reconstruct social support network of substance abusers has been caused for concern. Studies demonstrated gender dif [....] » Read More

Isabella Ingram, Speaker at Speaker for GAB Conferences- Isabella Ingram
Poster Presentation
Isabella Ingram, School of Psychology, University of Wollongong, Australia

Introduction: Loneliness is a distressing emotional experience that is problematic for people accessing treatment for substance dependence problems. The first aim of the current study was to report on the validity of the Social and Emotional Loneliness Scale for Adults-Short [....] » Read More

Scientific Programs coming soon..

Watsapp